Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Primary objective- To determine efficacy of Avastin, 10 mg/kg every other week, in
combination with standard 5-day temozolomide in terms of response rate.
Secondary objective- To determine safety of Avastin & Temozolomide in unresectable
glioblastoma patients